Bright Minds Biosciences (XCNQ:DRUG) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences Dividend Payout Ratio?

Bright Minds Biosciences's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Bright Minds Biosciences's Dividend Payout Ratio or its related term are showing as below:

XCNQ:DRUG's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.415
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-02), the Dividend Yield % of Bright Minds Biosciences is 0.00%.

Bright Minds Biosciences's Dividends per Share for the months ended in Dec. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Bright Minds Biosciences Dividend Payout Ratio Historical Data

The historical data trend for Bright Minds Biosciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences Dividend Payout Ratio Chart

Bright Minds Biosciences Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Dividend Payout Ratio

Bright Minds Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Bright Minds Biosciences's Dividend Payout Ratio

For the Biotechnology subindustry, Bright Minds Biosciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bright Minds Biosciences's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bright Minds Biosciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bright Minds Biosciences's Dividend Payout Ratio falls into.

Bright Minds Biosciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Bright Minds Biosciences's Dividend Payout Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Sep. 2023 )	/	EPS without NRI (A: Sep. 2023 )
	=	0	/	-1.984
	=	N/A

Bright Minds Biosciences's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.444
	=	N/A

Bright Minds Biosciences (XCNQ:DRUG) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Bright Minds Biosciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Minds Biosciences (XCNQ:DRUG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (XCNQ:DRUG) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

DRUG:USA

Address

19 Vestry Street, New York, NY, USA, 10013

Website

https://www.brightmindsbio.com

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.